Published online Apr 21, 2021. doi: 10.3748/wjg.v27.i15.1616
Peer-review started: January 28, 2021
First decision: February 24, 2021
Revised: March 5, 2021
Accepted: March 29, 2021
Article in press: March 29, 2021
Published online: April 21, 2021
Processing time: 75 Days and 15.2 Hours
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer type, since it is usually diagnosed late, it has a very poor prognosis and strong chemoresistance. In the tumour microenvironment, cancer cells and other cell types co-exist and communicate by exchanging several molecules, including the chemokine CXCL12.
CXCL12 pre-mRNA can be alternatively spliced into different isoforms (α, β, γ, δ, ε, θ). However, their specific roles in PDAC have not yet been fully described.
Here, we aim to evaluate the specific roles of the main CXCL12 isoforms (α, β, and γ) in PDAC onset.
We administered α, β, and γ CXCL12 isoforms to a pre-tumour model of PDAC, i.e., the hTERT-HPNE E6/E7/KRasG12D cells. Then, we performed microarray analysis and Real-Time polymerase chain reaction validation in order to evaluate the global gene expression alterations. We also carried out wound healing assays in order to evaluate the effect of α, β, and γ CXCL12 isoforms on the cell migration ability.
The transcriptomic analyses showed that the expression of only few genes was affected by the treatment with the three isoforms. In particular, α and β isoforms affect different genes, whereas γ isoform altered the expression of genes already affected by the other isoforms. Since many genes affected by all isoforms are involved in cell migration and cytoskeleton remodelling, we performed cell migration assays, which confirmed the role of CXCL12 in migration, mainly caused by the γ isoform.
Our results suggest that α, β and γ CXCL12 isoforms can trigger different responses in a pancreatic pre-tumour model. The γ isoform induced the highest level of cell migration.
Although our data shed light on the molecular basis of PDAC onset and progression, further studies are necessary for a deeper characterization of CXCL12 isoforms.